Format
Sort by

Send to

Choose Destination

Search results

Items: 12

1.

Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45.

Helander A, Bradley M, Hasselblad A, Norlén L, Vassilaki I, Bäckberg M, Lapins J.

Br J Dermatol. 2016 Dec 14. doi: 10.1111/bjd.15174. [Epub ahead of print]

PMID:
27976363
2.

Majocchis Granuloma Caused by Trichophyton mentagrophytes in 2 Immunocompetent Patients.

Trocoli Drakensjö I, Vassilaki I, Bradley M.

Actas Dermosifiliogr. 2017 Jan - Feb;108(1):e6-e8. doi: 10.1016/j.ad.2015.05.020. English, Spanish.

PMID:
26952202
3.

BRAFV600E protein expression in primary cutaneous malignant melanomas and paired metastases.

Eriksson H, Zebary A, Vassilaki I, Omholt K, Ghaderi M, Hansson J.

JAMA Dermatol. 2015 Apr;151(4):410-6. doi: 10.1001/jamadermatol.2014.3689.

PMID:
25588152
4.

Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study.

Eriksson H, Frohm-Nilsson M, Järås J, Kanter-Lewensohn L, Kjellman P, Månsson-Brahme E, Vassilaki I, Hansson J.

Br J Dermatol. 2015 Jan;172(1):175-86. doi: 10.1111/bjd.13171.

PMID:
24910143
5.

KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma.

Zebary A, Omholt K, Vassilaki I, Höiom V, Lindén D, Viberg L, Kanter-Lewensohn L, Johansson CH, Hansson J.

J Dermatol Sci. 2013 Dec;72(3):284-9. doi: 10.1016/j.jdermsci.2013.07.013.

PMID:
23993026
6.

Simultaneous visualization of Propionibacterium acnes and Propionibacterium granulosum with immunofluorescence and fluorescence in situ hybridization.

Jahns AC, Oprica C, Vassilaki I, Golovleva I, Palmer RH, Alexeyev OA.

Anaerobe. 2013 Oct;23:48-54. doi: 10.1016/j.anaerobe.2013.07.002.

PMID:
23896347
7.

Somatic BRAF and NRAS mutations in familial melanomas with known germline CDKN2A status: a GenoMEL study.

Zebary A, Omholt K, van Doorn R, Ghiorzo P, Harbst K, Hertzman Johansson C, Höiom V, Jönsson G, Pjanova D, Puig S, Scarra GB, Harland M, Olsson H, Egyhazi Brage S, Palmer J, Kanter-Lewensohn L, Vassilaki I, Hayward NK, Newton-Bishop J, Gruis NA, Hansson J; Melanoma Genetics Consortium (GenoMEL)..

J Invest Dermatol. 2014 Jan;134(1):287-90. doi: 10.1038/jid.2013.270. No abstract available.

9.

Concomitant juvenile xanthogranuloma and cutaneous mastocytosis in a 3-year-old Swedish girl: case report and review of the literature.

Gruber R, Vassilaki I, Zelger B.

Int J Dermatol. 2011 May;50(5):611-4. doi: 10.1111/j.1365-4632.2010.04553.x. Review. No abstract available.

PMID:
21349079
10.

High Ro52 expression in spontaneous and UV-induced cutaneous inflammation.

Oke V, Vassilaki I, Espinosa A, Strandberg L, Kuchroo VK, Nyberg F, Wahren-Herlenius M.

J Invest Dermatol. 2009 Aug;129(8):2000-10. doi: 10.1038/jid.2008.453.

11.

Feasibility and diagnostic agreement in teledermatopathology using a virtual slide system.

Massone C, Soyer HP, Lozzi GP, Di Stefani A, Leinweber B, Gabler G, Asgari M, Boldrini R, Bugatti L, Canzonieri V, Ferrara G, Kodama K, Mehregan D, Rongioletti F, Janjua SA, Mashayekhi V, Vassilaki I, Zelger B, Zgavec B, Cerroni L, Kerl H.

Hum Pathol. 2007 Apr;38(4):546-54.

PMID:
17270240
12.

Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid.

Heilborn JD, Ståhle-Bäckdahl M, Albertioni F, Vassilaki I, Peterson C, Stephansson E.

J Am Acad Dermatol. 1999 May;40(5 Pt 1):741-9.

PMID:
10321603
Items per page

Supplemental Content

Loading ...
Support Center